Labs / ADME, DMPK & toxicology
Arvinas
New Haven, CT, United States · arvinas.com
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
Arvinas is a biotechnology company focused on targeted protein degradation therapeutics. It develops PROTAC-based medicines for serious diseases, with programs in oncology and neurology, from New Haven, Connecticut.
Their website has a general contact form; we send your quote request through it.
What they offer
PROTAC Discovery Engine
Develops targeted protein degraders using a platform that combines human biology target selection, E3 ligase expertise, chemistry, structural biology, proteomics, AI/ML, and PK/PD modeling.
Drug discovery and development for targeted protein degradation
Advances clinical-stage PROTAC programs and investigational therapies designed to degrade disease-causing proteins.
Oncology program development
Develops targeted protein degradation therapeutics for oncology targets and disease pathways.
Neurology program development
Develops targeted protein degradation therapeutics for neurology targets and disease pathways.
Clinical trial advancement
Advances PROTAC degraders into clinical trials and clinical-stage programs.
Partnerships with drug development companies
Partners with other drug development companies to advance PROTAC programs.
What they work on
- Modalities
- Small molecule
- Assays and studies
- pharmacodynamic (PD) models, efficacy models, pharmacokinetic (PK)/PD modeling, global proteomics profiling
- Therapeutic areas
- oncology, neurology
- Sites
- New Haven, United States
- Address
- 5 Science Park 395 Winchester Ave. New Haven, CT 06511
- Founded
- 2013
Similar labs. Aclairo Pharmaceutical Development Group, Inc., ACM Global Laboratories, Allumiqs, Alpha Genesis, Inc.
Found in a contract services directory. Listing built from arvinas.com. Work here? Claim this listing.